San Francisco-based Omada Health has received new funding of $73 million to fuel the expansion of its digital care program, including support for those with type 2 diabetes and hypertension, as well as people dealing with anxiety and depression.
Omada works with more than 600 employers and health plans, delivering an integrated experience that adapts to participants’ health needs, and personalizes their journeys to create the best health outcomes. The company is the nation’s largest CDC-recognized provider of the National Diabetes Prevention Program, and has now launched programs over the last year for diabetes self-management, as well as anxiety and depression, to holistically address individuals’ health needs.
Omada has published 11 peer-reviewed studies, and is currently running the largest-ever randomized controlled trial of digital diabetes prevention.
“Today’s announcement — and the incredible roster of investors participating in this round of fundraising — will deepen our collaboration with health plans, employers, and health systems, and accelerate the development of our truly personalized program that helps participants build patterns for lifelong health,” said Omada Health CEO and co-founder Sean Duffy in a statement.
The new round of funding was led by Wellington Management Company LLP. Also participating in the round were previous investors Cigna Ventures, Andreessen Horowitz, U.S. Venture Partners, Norwest Venture Partners, Kaiser Permanente Ventures, Sanofi Ventures, Civilization Ventures and Providence Ventures.
